(Q73204431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M Younes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M R Schwartz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Finnie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Younes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1309-1313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Epression of the Apoptosis-Inducing FAS Ligand (FASL) in Human First and Third Trimester Placenta and Choriocarcinoma Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

The role of FasL-induced apoptosis in immune privilege

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Fas ligand and immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

Barrett's esophagus, dysplasia, and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2899%2990061-8

7 January 2021

10.1016/S0046-8177(99)90061-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10571510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference